PDF
Eine seltene, aber wichtige Ursache einer linksventrikulären Hypertrophie. Seit 2001 wurde mit der Enzymersatztherapie erstmals eine kausale Therapie möglich.
It is crucial to establish the correct diagnosis, as some bradyarrhythmias have an excellent prognosis and do not require treatment whereas others can be life threatening.
Heart transplantation has made tremendous progress since its first clinical use in 1968 and has enabled survival of many patients with intractable heart failure. A pioneer of the Swiss heart transplant programme looks back.
Results of the Special Programme University Medicine Study (SPUM-ACS): With current stent technology and guideline-based ACS management, stent thrombosis is rare.
FDG-PET/CT enables direct visualisation of inflammatory activity and may represent a useful tool for diagnosis, risk stratification and therapy monitoring in patients with pericarditis.
The new electronic ESC Textbook of Cardiovascular Medicine
A platform for postgraduate education and scientific work.
EMH on Facebook
E-mail alerts
Newsletter for advertisers
Cardiovascular Medicine EMH Swiss Medical Publishers Ltd. Farnsburgerstrasse 8 CH-4132 Muttenz Tel. +41 (0)61 467 85 55 Fax +41 (0)61 467 85 56 e-mail: Editorial office
Privacy policy
EMH MediaSchweizerische ÄrztezeitungSwiss Medical ForumPrimary and Hospital CareSwiss Archives of Neurology, Psychiatry and PsychotherapySwiss Medical Informatics
In order to offer you a better user experience, we use cookies. Additional information can be found here.